120 related articles for article (PubMed ID: 36357623)
1. Blood metabolomes as non-invasive biomarkers and targets of metabolic interventions for doxorubicin and trastuzumab-induced cardiotoxicity.
Thonusin C; Nawara W; Khuanjing T; Prathumsup N; Arinno A; Ongnok B; Arunsak B; Sriwichaiin S; Chattipakorn SC; Chattipakorn N
Arch Toxicol; 2023 Feb; 97(2):603-618. PubMed ID: 36357623
[TBL] [Abstract][Full Text] [Related]
2. Changes in blood metabolomes as potential markers for severity and prognosis in doxorubicin-induced cardiotoxicity: a study in HER2-positive and HER2-negative breast cancer patients.
Thonusin C; Osataphan N; Leemasawat K; Nawara W; Sriwichaiin S; Supakham S; Gunaparn S; Apaijai N; Somwangprasert A; Phrommintikul A; Chattipakorn SC; Chattipakorn N
J Transl Med; 2024 Apr; 22(1):398. PubMed ID: 38685030
[TBL] [Abstract][Full Text] [Related]
3. Effects of melatonin on cardiac metabolic reprogramming in doxorubicin-induced heart failure rats: A metabolomics study for potential therapeutic targets.
Thonusin C; Nawara W; Arinno A; Khuanjing T; Prathumsup N; Ongnok B; Chattipakorn SC; Chattipakorn N
J Pineal Res; 2023 Aug; 75(1):e12884. PubMed ID: 37177873
[TBL] [Abstract][Full Text] [Related]
4. Early metabolomics changes in heart and plasma during chronic doxorubicin treatment in B6C3F1 mice.
Schnackenberg LK; Pence L; Vijay V; Moland CL; George N; Cao Z; Yu LR; Fuscoe JC; Beger RD; Desai VG
J Appl Toxicol; 2016 Nov; 36(11):1486-95. PubMed ID: 26934058
[TBL] [Abstract][Full Text] [Related]
5. Overweight in mice, induced by perinatal programming, exacerbates doxorubicin and trastuzumab cardiotoxicity.
Guenancia C; Hachet O; Aboutabl M; Li N; Rigal E; Cottin Y; Rochette L; Vergely C
Cancer Chemother Pharmacol; 2016 Apr; 77(4):777-85. PubMed ID: 26914236
[TBL] [Abstract][Full Text] [Related]
6. Which sequence best protects the heart against trastuzumab and anthracycline toxicity? An electron microscopy study in rats.
Kertmen N; Aksoy S; Uner A; Sargon M; Ozkayar O; Keskin O; Babacan T; Sarici F; Sendur MA; Arik Z; Akin S; Altundag K
Anticancer Res; 2015 Feb; 35(2):857-64. PubMed ID: 25667467
[TBL] [Abstract][Full Text] [Related]
7. Melatonin and metformin ameliorated trastuzumab-induced cardiotoxicity through the modulation of mitochondrial function and dynamics without reducing its anticancer efficacy.
Arinno A; Maneechote C; Khuanjing T; Prathumsap N; Chunchai T; Arunsak B; Nawara W; Kerdphoo S; Shinlapawittayatorn K; Chattipakorn SC; Chattipakorn N
Biochim Biophys Acta Mol Basis Dis; 2023 Feb; 1869(2):166618. PubMed ID: 36494039
[TBL] [Abstract][Full Text] [Related]
8. Cardioprotective effects of melatonin and metformin against doxorubicin-induced cardiotoxicity in rats are through preserving mitochondrial function and dynamics.
Arinno A; Maneechote C; Khuanjing T; Ongnok B; Prathumsap N; Chunchai T; Arunsak B; Kerdphoo S; Shinlapawittayatorn K; Chattipakorn SC; Chattipakorn N
Biochem Pharmacol; 2021 Oct; 192():114743. PubMed ID: 34453902
[TBL] [Abstract][Full Text] [Related]
9. Protective Effect of Curcumin, Chrysin and Thymoquinone Injection on Trastuzumab-Induced Cardiotoxicity via Mitochondrial Protection.
Shirmard LR; Shabani M; Moghadam AA; Zamani N; Ghanbari H; Salimi A
Cardiovasc Toxicol; 2022 Jul; 22(7):663-675. PubMed ID: 35567651
[TBL] [Abstract][Full Text] [Related]
10. Promoting mitochondrial fusion in doxorubicin-induced cardiotoxicity: a novel therapeutic target for cardioprotection.
Maneechote C; Khuanjing T; Ongnok B; Arinno A; Prathumsap N; Chunchai T; Arunsak B; Nawara W; Chattipakorn SC; Chattipakorn N
Clin Sci (Lond); 2022 Jun; 136(11):841-860. PubMed ID: 35543245
[TBL] [Abstract][Full Text] [Related]
11. Vagus nerve stimulation and acetylcholinesterase inhibitor donepezil provide cardioprotection against trastuzumab-induced cardiotoxicity in rats by attenuating mitochondrial dysfunction.
Khuanjing T; Maneechote C; Ongnok B; Prathumsap N; Arinno A; Chunchai T; Arunsak B; Chattipakorn SC; Chattipakorn N
Biochem Pharmacol; 2023 Nov; 217():115836. PubMed ID: 37816466
[TBL] [Abstract][Full Text] [Related]
12. Prophylactic Evidence of MSCs-Derived Exosomes in Doxorubicin/Trastuzumab-Induced Cardiotoxicity: Beyond Mechanistic Target of NRG-1/Erb Signaling Pathway.
Ebrahim N; Al Saihati HA; Mostafa O; Hassouna A; Abdulsamea S; Abd El Aziz M El Gebaly E; Abo-Rayah NH; Sabry D; El-Sherbiny M; Madboly AG; Hussien NI; Saadani REH; Ebrahim HA; Badr OAM; Elsherbiny NM; Salim RF
Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682646
[TBL] [Abstract][Full Text] [Related]
13. Effect of gemfibrozil on cardiotoxicity induced by doxorubicin in male experimental rats.
Haybar H; Goudarzi M; Mehrzadi S; Aminzadeh A; Khodayar MJ; Kalantar M; Fatemi I
Biomed Pharmacother; 2019 Jan; 109():530-535. PubMed ID: 30551518
[TBL] [Abstract][Full Text] [Related]
14. Longitudinal Changes in Multiple Biomarkers Are Associated with Cardiotoxicity in Breast Cancer Patients Treated with Doxorubicin, Taxanes, and Trastuzumab.
Putt M; Hahn VS; Januzzi JL; Sawaya H; Sebag IA; Plana JC; Picard MH; Carver JR; Halpern EF; Kuter I; Passeri J; Cohen V; Banchs J; Martin RP; Gerszten RE; Scherrer-Crosbie M; Ky B
Clin Chem; 2015 Sep; 61(9):1164-72. PubMed ID: 26220066
[TBL] [Abstract][Full Text] [Related]
15. Cardiac Safety of Dual Anti-HER2 Therapy in the Neoadjuvant Setting for Treatment of HER2-Positive Breast Cancer.
Yu AF; Singh JC; Wang R; Liu JE; Eaton A; Oeffinger KC; Steingart RM; Hudis CA; Dang CT
Oncologist; 2017 Jun; 22(6):642-647. PubMed ID: 28341761
[TBL] [Abstract][Full Text] [Related]
16. Dipyridamole ameliorates doxorubicin-induced cardiotoxicity.
Alyasiry E; Janabi A; Hadi N
J Med Life; 2022 Sep; 15(9):1184-1190. PubMed ID: 36415530
[TBL] [Abstract][Full Text] [Related]
17. Intravenous administration of cardiac progenitor cell-derived exosomes protects against doxorubicin/trastuzumab-induced cardiac toxicity.
Milano G; Biemmi V; Lazzarini E; Balbi C; Ciullo A; Bolis S; Ameri P; Di Silvestre D; Mauri P; Barile L; Vassalli G
Cardiovasc Res; 2020 Feb; 116(2):383-392. PubMed ID: 31098627
[TBL] [Abstract][Full Text] [Related]
18. Rat Model of Cardiotoxic Drug-Induced Cardiomyopathy.
Nakahara T; Tanimoto T; Petrov AD; Ishikawa K; Strauss HW; Narula J
Methods Mol Biol; 2018; 1816():221-232. PubMed ID: 29987823
[TBL] [Abstract][Full Text] [Related]
19. Genotoxicity, nitric oxide level modulation and cardio-protective potential of Kalanchoe Integra Var. Crenata (Andr.) Cuf Leaves in murine models.
Asiedu-Gyekye IJ; Arhin E; Arthur SA; N'guessan BB; Amponsah SK
J Ethnopharmacol; 2022 Jan; 283():114640. PubMed ID: 34606947
[TBL] [Abstract][Full Text] [Related]
20. Comparing Flaxseed and Perindopril in the Prevention of Doxorubicin and Trastuzumab-Induced Cardiotoxicity in C57Bl/6 Mice.
Eekhoudt CR; Bortoluzzi T; Varghese SS; Cheung DYC; Christie S; Eastman S; Mittal I; Austria JA; Aukema HM; Ravandi A; Thliveris J; Singal PK; Jassal DS
Curr Oncol; 2022 Apr; 29(5):2941-2953. PubMed ID: 35621631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
